Enhanced bio-production of difficult to make peptide ingredients for specialty adhesives and personal care

到2050年，人类社会预计需要的资源大约是地球维持自身所能提供的资源的两倍。公众对这一问题的认识导致了对可持续产品的需求增加，并重新引起了人们对受自然启发的可持续替代品的兴趣。生物材料可以在一系列领域提供有效的解决方案，创造出性能更好、碳足迹更少的产品。然而，生物材料的广泛应用历来受到其成本、规模生产的困难和伦理问题的限制。Zentraxa的生物生产平台Zentide允许我们发酵特殊的生物材料。Zentide简化了难以制造的生物材料的生产，使我们的材料实现了突破性的成本效益和生产规模。这使我们能够提供满足不断变化的需求并可轻松应用于一系列新市场的高性能生物材料。Zentraxa以前曾开发出新型生物胶，用于医疗应用中的皮肤粘合，如敷料和密封物。以前的平台开发侧重于这些粘合剂产品的生产，以提供特定利基应用的用例演示。在这个项目中，我们的目标是提高我们平台的生产效率，并进行改进，以实现更大规模的生产，以更高的效率和更低的成本。我们还打算扩大可生产材料的范围，并随后将这些材料应用于新市场的问题，如个人护理(护肤霜/头发护理)和特种粘合剂(用于汽车和传感器系统)。通过改进我们的平台，我们最终希望打破生物技术客户和新工业客户之间的壁垒，减少多肽的传统限制，使它们及其好处更容易获得，并在大量新市场上可行。

By 2050, human society is expected to require roughly twice the resources the planet is able to supply to sustain itself. Public awareness of this issue has resulted in an increased demand for sustainable products, and a renewed interest in nature-inspired sustainable alternatives. Biomaterials can be used to provide efficient solutions in a range of areas, creating products that display improved performance and a decreased carbon footprint.However, wide-scale application of biomaterials is historically limited by their costs, difficulties in scaling their production and ethical concerns. Zentraxa's bio-production platform Zentide allows us to ferment specialty biomaterials. Zentide simplifies the production of difficult to make biomaterials allowing us to achieve breakthrough cost economics and scale of production for our materials. This allows us to deliver high-performance biomaterials that meet changing demands and can be easily applied to a range of new markets.Zentraxa have previously developed new types of biological glue for use in skin bonding for medical applications such as dressings & seals. Previous platform development has focused on the production of these adhesive products to deliver use-case demonstrations of specific niche applications. During this project, we aim to improve the production efficiency of our platform and make improvements allowing for production on a larger scale, with greater efficiency and lower cost. We also intend to expand the range of producible materials, and subsequently to apply these to problems in new markets such as personal care (skin creams / hair treatments) and specialty adhesives (for cars and sensor systems). By improving our platform, we ultimately hope to break down the barriers between biotech & new industrial customers, reducing the conventional restrictions of peptides making them and their benefits more accessible & viable for a wealth of new markets.